Know Cancer

or
forgot password

A Double-Blind, Placebo-Controlled Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares


Phase 2
18 Years
N/A
Not Enrolling
Both
Verrucae Vulgares

Thank you

Trial Information

A Double-Blind, Placebo-Controlled Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares


A Double-blind, placebo-controlled trial investigating the effect of a treatment with
zinkgluconaat for verrucae vulgares


Inclusion Criteria:



- Patients with verrucae vulgares

Exclusion Criteria:

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Outcome Measure:

Disappearence of the verrucae vulgares after 3 months

Principal Investigator

Annelies Stockman, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University Hospital, Ghent

Authority:

Belgium: Institutional Review Board

Study ID:

2004/005

NCT ID:

NCT00228332

Start Date:

April 2004

Completion Date:

March 2006

Related Keywords:

  • Verrucae Vulgares
  • Warts

Name

Location